ReviewTurkish journal of urology2013

The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.

Mehmet Umul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.